These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 9499754)
1. Practical issues regarding the use of antiretroviral therapy for HIV infection. Deeks SG West J Med; 1998 Feb; 168(2):133-9. PubMed ID: 9499754 [TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
6. Antiretroviral update: recent advances expand options for patients with HIV. Santhanam H; Goins M Adv Nurse Pract; 2004 Nov; 12(11):53-4, 56. PubMed ID: 15559568 [No Abstract] [Full Text] [Related]
7. New antiretrovirals and new combinations. Havlir DV; Lange JM AIDS; 1998; 12 Suppl A():S165-74. PubMed ID: 9632999 [TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy in human immunodeficiency virus-infected individuals. Spooner KM Adv Intern Med; 1998; 43():373-402. PubMed ID: 9506188 [No Abstract] [Full Text] [Related]
9. Rationale and experience with reverse transcriptase inhibitors and protease inhibitors. Vella S J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S58-61. PubMed ID: 8595511 [TBL] [Abstract][Full Text] [Related]
10. State of the art: antiretroviral and prophylactic treatments in HIV/AIDS. Porche DJ Nurs Clin North Am; 1999 Mar; 34(1):95-112. PubMed ID: 9922281 [TBL] [Abstract][Full Text] [Related]
11. Using pharmacokinetics to optimize antiretroviral drug-drug interactions in the treatment of human immunodeficiency virus infection. Gerber JG Clin Infect Dis; 2000 Jun; 30 Suppl 2():S123-9. PubMed ID: 10860896 [TBL] [Abstract][Full Text] [Related]
12. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations. Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885 [No Abstract] [Full Text] [Related]
13. Salvage therapy for patients failing their current antiretroviral regimen. Albrecht MA AIDS Clin Rev; 2000-2001; ():139-91. PubMed ID: 10999220 [No Abstract] [Full Text] [Related]
14. HIV resistance: the new enemy. Colvin R Common Factor; 1997 Nov; (No 11):6-7. PubMed ID: 11364845 [TBL] [Abstract][Full Text] [Related]
15. Guidelines for the treatment of HIV. Newsline People AIDS Coalit N Y; 1999 Jan; ():31-3. PubMed ID: 11367185 [TBL] [Abstract][Full Text] [Related]
16. Combination antiretroviral therapy for HIV infection. Maenza J; Flexner C Am Fam Physician; 1998 Jun; 57(11):2789-98. PubMed ID: 9636341 [TBL] [Abstract][Full Text] [Related]
17. New antiretroviral tactics: transitions or mere trends? An interview with Joep Lange,MD,PhD. Interview by Mark Mascolini. Mascolini M J Int Assoc Physicians AIDS Care; 1999 Jul; 5(7):25-9. PubMed ID: 11367133 [TBL] [Abstract][Full Text] [Related]
18. Is there a role for non-nucleoside reverse transcriptase inhibitors in the treatment of HIV infection? Kilby JM; Saag MS Infect Agents Dis; 1994 Dec; 3(6):313-23. PubMed ID: 7534192 [TBL] [Abstract][Full Text] [Related]
19. Current approaches to treatment for HIV-1 infection. Powderly WG J Neurovirol; 2000 May; 6 Suppl 1():S8-S13. PubMed ID: 10871760 [TBL] [Abstract][Full Text] [Related]